[Federal Register Volume 85, Number 50 (Friday, March 13, 2020)]
[Notices]
[Pages 14703-14704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05125]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-1472 (Preliminary)]


Difluoromethane (R-32) From China

Determinations

    On the basis of the record \1\ developed in the subject 
investigation, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that there is a reasonable indication that an industry in the 
United States is materially injured by reason of imports of 
difluoromethane (R-32) from China, provided for in subheadings 
2903.39.20 and 3824.78.00 of the Harmonized Tariff Schedule of the 
United States, that are alleged to be sold in the United States at less 
than fair value (``LTFV'').\2\
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
    \2\ Difluoromethane (R-32) from China: Initiation of Less-Than-
Fair-Value Investigation (85 FR 10406, February 24, 2020).
---------------------------------------------------------------------------

Commencement of Final Phase Investigation

    Pursuant to section 207.18 of the Commission's rules, the 
Commission also gives notice of the commencement of the final phase of 
its investigation. The Commission will issue a final phase notice of 
scheduling, which will be published in the Federal Register as provided 
in section 207.21 of the Commission's rules, upon notice from the U.S. 
Department of Commerce (``Commerce'') of an affirmative preliminary 
determination in the investigation under sections 703(b) or 733(b) of 
the Act, or, if the preliminary determination is negative, upon notice 
of an affirmative final determination in this investigation under 
sections 705(a) or 735(a) of the Act. Parties that filed entries of 
appearance in the preliminary phase of the investigation need not enter 
a separate appearance for the final phase of the investigation. 
Industrial users, and, if the merchandise under investigation is sold 
at the retail level,

[[Page 14704]]

representative consumer organizations have the right to appear as 
parties in Commission antidumping duty investigations. The Secretary 
will prepare a public service list containing the names and addresses 
of all persons, or their representatives, who are parties to the 
investigation.

Background

    On January 23, 2020, Arkema Inc., King of Prussia, Pennsylvania 
filed a petition with the Commission and Commerce, alleging that an 
industry in the United States is materially injured or threatened with 
material injury by reason of LTFV imports of R-32 from China. 
Accordingly, effective January 23, 2020, the Commission, pursuant to 
section 733(a) of the Act (19 U.S.C. 1673b(a)), instituted antidumping 
duty investigation No. 731-TA-1472 (Preliminary).
    Notice of the institution of the Commission's investigation and of 
a public conference to be held in connection therewith was given by 
posting copies of the notice in the Office of the Secretary, U.S. 
International Trade Commission, Washington, DC, and by publishing the 
notice in the Federal Register of January 29, 2020 (85 FR 5239). The 
conference was held in Washington, DC, on February 13, 2020, and all 
persons who requested the opportunity were permitted to appear in 
person or by counsel.
    The Commission made this determination pursuant to section733(a) of 
the Act (19 U.S.C. 1673b(a)). It completed and filed its determination 
in this investigation on March 9, 2020. The views of the Commission are 
contained in USITC Publication 5036 (March 2020), entitled 
Difluoromethane (R-32) from China: Investigation No. 731-TA-1472 
(Preliminary).

    By order of the Commission.

    Issued: March 9, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020-05125 Filed 3-12-20; 8:45 am]
 BILLING CODE 7020-02-P